
FMC Corporation announced a framework agreement to sell its Newark, Delaware property for about $114 million, with plans to lease back the facilities it uses. The sale aims to optimize FMC's asset base by converting underused real estate into capital to reduce debt, while keeping its global R&D headquarters, the Stine Research Center, operational. The transaction is expected to close in Q4 2026, subject to due diligence and final agreement on lease terms. This move supports FMC's strategy to strengthen its financial position without disrupting its core research and growth capabilities.